Survival of AIDS Patients in Croatia Prior to the Introduction of Combined Antiretroviral Therapy with Protease Inhibitors
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We report our experience on survival of adults with AIDS, treated at the University Hospital of Infectious Diseases, Zagreb, Croatia from October 1986 to December 1998. The median survival of our 116 patients was 15.8 months. Multivariate analysis showed that factors independently associated with survival were type of presenting AIDS indicator disease and CD4+ cell count.
References
1.
Lundgren J, Pedersen C, Clumeck N, Gatell J, Johnson A, Ledergerber B
. Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ. 1994; 308(6936):1068-73.
PMC: 2539932.
DOI: 10.1136/bmj.308.6936.1068.
View
2.
Pezzotti P, Napoli P, Acciai S, Boros S, Urciuoli R, Lazzeri V
. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group. AIDS. 1999; 13(2):249-55.
DOI: 10.1097/00002030-199902040-00013.
View
3.
Mocroft A, Youle M, Morcinek J, Sabin C, Gazzard B, Johnson M
. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. BMJ. 1997; 314(7078):409-13.
PMC: 2125908.
DOI: 10.1136/bmj.314.7078.409.
View
4.
Dehne K, Khodakevich L, Hamers F, Schwartlander B
. The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-making. AIDS. 1999; 13(7):741-9.
DOI: 10.1097/00002030-199905070-00002.
View
5.
Mann J, Chin J, Piot P, Quinn T
. The international epidemiology of AIDS. Sci Am. 1988; 259(4):82-9.
DOI: 10.1038/scientificamerican1088-82.
View